Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Clinical Investigation|February 24, 2007
Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver diseaseVarman T Samuel, Zhen-Xiang Liu, Amy Wang, et al.
Diabetes|June 29, 2006
Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin actionVarman T Samuel, Cheol Soo Choi, Trevor G Phillips, et al.
Endocrinology|November 17, 2018
PEPCK1 Antisense Oligonucleotide Prevents Adiposity and Impairs Hepatic Glycogen Synthesis in High-Fat Male Fed RatsSara A Beddow, Arijeet K Gattu, Daniel F Vatner, et al.
The Journal of Clinical Investigation|February 18, 2006
Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2David B Savage, Cheol Soo Choi, Varman T Samuel, et al.
European Journal of Medicinal Chemistry|July 24, 2017
Indazole-based ligands for estrogen-related receptor α as potential anti-diabetic agentsRaymond J Patch, Hui Huang, Sharmila Patel, et al.
Journal of Medicinal Chemistry|January 12, 2011
Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agentsRaymond J Patch, Lily L Searle, Alexander J Kim, et al.
Journal of Lipid Research|April 12, 2012
The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2Jenson Qi, Wensheng Lang, John G Geisler, et al.
Geroscience|May 16, 2024
Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozinRichard A Miller, David E Harrison, Gino A Cortopassi, et al.
Pageof 3